nodes	percent_of_prediction	percent_of_DWPC	metapath
Aminophenazone—CYP17A1—Androgen biosynthesis—CGA—conduct disorder	0.318	0.318	CbGpPWpGaD
Aminophenazone—CYP17A1—Metabolism of steroid hormones and vitamin D—CGA—conduct disorder	0.132	0.132	CbGpPWpGaD
Aminophenazone—CYP1A2—Methylation—COMT—conduct disorder	0.0355	0.0355	CbGpPWpGaD
Aminophenazone—CYP17A1—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.0298	0.0298	CbGpPWpGaD
Aminophenazone—CYP2C18—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.0236	0.0236	CbGpPWpGaD
Aminophenazone—CYP1A2—Estrogen metabolism—COMT—conduct disorder	0.0222	0.0222	CbGpPWpGaD
Aminophenazone—CYP2C19—Melatonin metabolism and effects—MAOA—conduct disorder	0.0193	0.0193	CbGpPWpGaD
Aminophenazone—CYP2D6—Melatonin metabolism and effects—MAOA—conduct disorder	0.0178	0.0178	CbGpPWpGaD
Aminophenazone—CYP3A4—Estrogen metabolism—COMT—conduct disorder	0.0171	0.0171	CbGpPWpGaD
Aminophenazone—CYP2C18—FOXA1 transcription factor network—EP300—conduct disorder	0.0161	0.0161	CbGpPWpGaD
Aminophenazone—CYP17A1—Biological oxidations—COMT—conduct disorder	0.0159	0.0159	CbGpPWpGaD
Aminophenazone—CYP17A1—Biological oxidations—MAOA—conduct disorder	0.0158	0.0158	CbGpPWpGaD
Aminophenazone—CYP17A1—Metapathway biotransformation—COMT—conduct disorder	0.0157	0.0157	CbGpPWpGaD
Aminophenazone—CYP3A7—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.0157	0.0157	CbGpPWpGaD
Aminophenazone—CYP1A2—Melatonin metabolism and effects—MAOA—conduct disorder	0.0151	0.0151	CbGpPWpGaD
Aminophenazone—CYP17A1—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.0136	0.0136	CbGpPWpGaD
Aminophenazone—CYP2C18—Biological oxidations—COMT—conduct disorder	0.0126	0.0126	CbGpPWpGaD
Aminophenazone—CYP2C18—Biological oxidations—MAOA—conduct disorder	0.0125	0.0125	CbGpPWpGaD
Aminophenazone—CYP2C18—Metapathway biotransformation—COMT—conduct disorder	0.0124	0.0124	CbGpPWpGaD
Aminophenazone—CYP2C8—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00981	0.00981	CbGpPWpGaD
Aminophenazone—CYP2C19—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00876	0.00876	CbGpPWpGaD
Aminophenazone—CYP3A7—Biological oxidations—COMT—conduct disorder	0.00838	0.00838	CbGpPWpGaD
Aminophenazone—CYP3A7—Biological oxidations—MAOA—conduct disorder	0.00832	0.00832	CbGpPWpGaD
Aminophenazone—CYP3A7—Metapathway biotransformation—COMT—conduct disorder	0.00827	0.00827	CbGpPWpGaD
Aminophenazone—CYP2D6—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00805	0.00805	CbGpPWpGaD
Aminophenazone—CYP2C9—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00798	0.00798	CbGpPWpGaD
Aminophenazone—SLC22A6—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.00761	0.00761	CbGpPWpGaD
Aminophenazone—CYP1A2—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00682	0.00682	CbGpPWpGaD
Aminophenazone—CYP1A2—Phase II conjugation—COMT—conduct disorder	0.00624	0.00624	CbGpPWpGaD
Aminophenazone—CYP17A1—Metabolism—CGA—conduct disorder	0.00604	0.00604	CbGpPWpGaD
Aminophenazone—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00526	0.00526	CbGpPWpGaD
Aminophenazone—CYP2C8—Biological oxidations—COMT—conduct disorder	0.00525	0.00525	CbGpPWpGaD
Aminophenazone—CYP2C8—Biological oxidations—MAOA—conduct disorder	0.00521	0.00521	CbGpPWpGaD
Aminophenazone—CYP2C8—Metapathway biotransformation—COMT—conduct disorder	0.00518	0.00518	CbGpPWpGaD
Aminophenazone—CYP2C18—Metabolism—CGA—conduct disorder	0.00478	0.00478	CbGpPWpGaD
Aminophenazone—CYP2C19—Biological oxidations—COMT—conduct disorder	0.00468	0.00468	CbGpPWpGaD
Aminophenazone—CYP2C19—Biological oxidations—MAOA—conduct disorder	0.00465	0.00465	CbGpPWpGaD
Aminophenazone—CYP2C19—Metapathway biotransformation—COMT—conduct disorder	0.00462	0.00462	CbGpPWpGaD
Aminophenazone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—conduct disorder	0.0045	0.0045	CbGpPWpGaD
Aminophenazone—CYP1A2—Aryl Hydrocarbon Receptor—EP300—conduct disorder	0.0045	0.0045	CbGpPWpGaD
Aminophenazone—CYP2C8—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.00446	0.00446	CbGpPWpGaD
Aminophenazone—CYP2D6—Biological oxidations—COMT—conduct disorder	0.00431	0.00431	CbGpPWpGaD
Aminophenazone—CYP2D6—Biological oxidations—MAOA—conduct disorder	0.00428	0.00428	CbGpPWpGaD
Aminophenazone—CYP2C9—Biological oxidations—COMT—conduct disorder	0.00427	0.00427	CbGpPWpGaD
Aminophenazone—CYP2D6—Metapathway biotransformation—COMT—conduct disorder	0.00425	0.00425	CbGpPWpGaD
Aminophenazone—CYP2C9—Biological oxidations—MAOA—conduct disorder	0.00424	0.00424	CbGpPWpGaD
Aminophenazone—CYP2C9—Metapathway biotransformation—COMT—conduct disorder	0.00421	0.00421	CbGpPWpGaD
Aminophenazone—CYP2C19—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.00398	0.00398	CbGpPWpGaD
Aminophenazone—CYP1A2—Biological oxidations—COMT—conduct disorder	0.00365	0.00365	CbGpPWpGaD
Aminophenazone—CYP2C9—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.00363	0.00363	CbGpPWpGaD
Aminophenazone—CYP1A2—Biological oxidations—MAOA—conduct disorder	0.00362	0.00362	CbGpPWpGaD
Aminophenazone—CYP1A2—Metapathway biotransformation—COMT—conduct disorder	0.0036	0.0036	CbGpPWpGaD
Aminophenazone—CYP3A7—Metabolism—CGA—conduct disorder	0.00318	0.00318	CbGpPWpGaD
Aminophenazone—CYP1A2—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.0031	0.0031	CbGpPWpGaD
Aminophenazone—CYP3A4—Biological oxidations—COMT—conduct disorder	0.00282	0.00282	CbGpPWpGaD
Aminophenazone—CYP3A4—Biological oxidations—MAOA—conduct disorder	0.0028	0.0028	CbGpPWpGaD
Aminophenazone—CYP3A4—Metapathway biotransformation—COMT—conduct disorder	0.00278	0.00278	CbGpPWpGaD
Aminophenazone—CYP17A1—Metabolism—COMT—conduct disorder	0.00272	0.00272	CbGpPWpGaD
Aminophenazone—CYP17A1—Metabolism—MAOA—conduct disorder	0.00271	0.00271	CbGpPWpGaD
Aminophenazone—CYP17A1—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.00262	0.00262	CbGpPWpGaD
Aminophenazone—CYP2C18—Metabolism—COMT—conduct disorder	0.00216	0.00216	CbGpPWpGaD
Aminophenazone—CYP2C18—Metabolism—MAOA—conduct disorder	0.00214	0.00214	CbGpPWpGaD
Aminophenazone—CYP2C8—Metabolism—CGA—conduct disorder	0.00199	0.00199	CbGpPWpGaD
Aminophenazone—CYP2C19—Metabolism—CGA—conduct disorder	0.00177	0.00177	CbGpPWpGaD
Aminophenazone—CYP2D6—Metabolism—CGA—conduct disorder	0.00163	0.00163	CbGpPWpGaD
Aminophenazone—CYP2C9—Metabolism—CGA—conduct disorder	0.00162	0.00162	CbGpPWpGaD
Aminophenazone—CYP3A7—Metabolism—COMT—conduct disorder	0.00143	0.00143	CbGpPWpGaD
Aminophenazone—CYP3A7—Metabolism—MAOA—conduct disorder	0.00142	0.00142	CbGpPWpGaD
Aminophenazone—CYP1A2—Metabolism—CGA—conduct disorder	0.00138	0.00138	CbGpPWpGaD
Aminophenazone—CYP17A1—Metabolism—EP300—conduct disorder	0.00117	0.00117	CbGpPWpGaD
Aminophenazone—CYP3A4—Metabolism—CGA—conduct disorder	0.00107	0.00107	CbGpPWpGaD
Aminophenazone—CYP2C18—Metabolism—EP300—conduct disorder	0.000925	0.000925	CbGpPWpGaD
Aminophenazone—CYP2C8—Metabolism—COMT—conduct disorder	0.000897	0.000897	CbGpPWpGaD
Aminophenazone—CYP2C8—Metabolism—MAOA—conduct disorder	0.000891	0.000891	CbGpPWpGaD
Aminophenazone—CYP2C8—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.000864	0.000864	CbGpPWpGaD
Aminophenazone—CYP2C19—Metabolism—COMT—conduct disorder	0.000801	0.000801	CbGpPWpGaD
Aminophenazone—CYP2C19—Metabolism—MAOA—conduct disorder	0.000795	0.000795	CbGpPWpGaD
Aminophenazone—CYP2C19—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.000771	0.000771	CbGpPWpGaD
Aminophenazone—CYP2D6—Metabolism—COMT—conduct disorder	0.000737	0.000737	CbGpPWpGaD
Aminophenazone—CYP2D6—Metabolism—MAOA—conduct disorder	0.000732	0.000732	CbGpPWpGaD
Aminophenazone—CYP2C9—Metabolism—COMT—conduct disorder	0.00073	0.00073	CbGpPWpGaD
Aminophenazone—CYP2C9—Metabolism—MAOA—conduct disorder	0.000725	0.000725	CbGpPWpGaD
Aminophenazone—CYP2C9—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.000703	0.000703	CbGpPWpGaD
Aminophenazone—CYP1A2—Metabolism—COMT—conduct disorder	0.000624	0.000624	CbGpPWpGaD
Aminophenazone—CYP1A2—Metabolism—MAOA—conduct disorder	0.00062	0.00062	CbGpPWpGaD
Aminophenazone—CYP3A7—Metabolism—EP300—conduct disorder	0.000615	0.000615	CbGpPWpGaD
Aminophenazone—CYP1A2—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.000601	0.000601	CbGpPWpGaD
Aminophenazone—CYP3A4—Metabolism—COMT—conduct disorder	0.000482	0.000482	CbGpPWpGaD
Aminophenazone—CYP3A4—Metabolism—MAOA—conduct disorder	0.000478	0.000478	CbGpPWpGaD
Aminophenazone—CYP2C8—Metabolism—EP300—conduct disorder	0.000385	0.000385	CbGpPWpGaD
Aminophenazone—CYP2C19—Metabolism—EP300—conduct disorder	0.000344	0.000344	CbGpPWpGaD
Aminophenazone—CYP2D6—Metabolism—EP300—conduct disorder	0.000316	0.000316	CbGpPWpGaD
Aminophenazone—CYP2C9—Metabolism—EP300—conduct disorder	0.000313	0.000313	CbGpPWpGaD
Aminophenazone—CYP1A2—Metabolism—EP300—conduct disorder	0.000268	0.000268	CbGpPWpGaD
Aminophenazone—CYP3A4—Metabolism—EP300—conduct disorder	0.000207	0.000207	CbGpPWpGaD
